Prevention in Recipients With Primary IgA Nephropathy of Recurrence After Kidney Transplantation: ATG-F Versus Basiliximab as Induction Immunosuppressive Treatment
Clinical trial NCT02523768 · TERMINATED
Trial details
- NCT number
- NCT02523768
- Sponsor
- Centre Hospitalier Universitaire de Saint Etienne
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-08
- Primary completion
- 2020-01-24
- Enrollment
- 117
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.